Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)

NCT03963544 · clinicaltrials.gov ↗

COMPLETED

Status

492

Enrollment

OTHER

Sponsor class

Conditions

Gastro Intestinal Stromal Tumor

Interventions

DRUG: oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations

Sponsor

Institut Bergonié

Collaborators

[object Object]